Pre-mRNA splicing regulation is critical for controlling macrophage activation
前 mRNA 剪接调节对于控制巨噬细胞激活至关重要
基本信息
- 批准号:10474615
- 负责人:
- 金额:$ 37.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Affinity ChromatographyAlternative SplicingAutomobile DrivingBiochemicalCell NucleusCellsChemicalsCodeComplexExcisionExonsGene ExpressionGeneticGenetic TranscriptionGoalsHeterogeneous-Nuclear Ribonucleoprotein Group MImmuneInflammation MediatorsInterleukin-6IntronsKnowledgeLipopolysaccharidesMacrophage ActivationMass Spectrum AnalysisMediatingModelingMolecularOrganellesOutcomePhosphorylationPost-Translational Protein ProcessingProtein DephosphorylationProtein SplicingRNARNA ProcessingRNA SplicingRNA-Binding ProteinsReadingRegulationResearchRoleSerineSignal TransductionSpliceosomesStarvationStimulusStressTranscriptViralcarcinogenesiscohortcombatcrosslinking and immunoprecipitation sequencingexperimental studyimmune activationknock-downmRNA Precursormacrophagepathogenphosphoproteomicsprogramsprotein protein interactionsmall hairpin RNAtranscriptome sequencing
项目摘要
PROJECT SUMMARY
Despite the substantial impact pre-mRNA splicing has on gene expression outcomes, little is known
about how the spliceosome itself is modified and regulated during cellular reprogramming. Innate immune cells
like macrophages reprogram gene expression when they sense a “danger signal,” such as a pathogen,
organelle damage, or chemical signal, to combat the detected threat. While changes that occur
transcriptionally during macrophage activation are well characterized, almost nothing is known about how pre-
mRNA splicing is regulated following immune stimuli. The long-term goal of this project is to uncover how
macrophage activation modifies the spliceosome and to connect these changes with innate immune gene
expression outcomes. The spliceosome is a complex and dynamic macromolecular machine. Its ability to
recognize introns and catalyze their removal relies on numerous RNA binding proteins that recognize specific
sequences in exons and introns to “read” the splicing code. The central hypothesis of this proposal is that
during macrophage activation, post-translational modification of splicing factors directs assembly of a
specialized spliceosome characterized by a distinct cohort of protein-protein interactions that promotes the
innate immune gene expression program. In support of this model, phosphoproteomic experiments reveal that
30+ splicing factors, many with known regulatory roles, are phosphorylated or dephosphorylated at specific
serine residues following lipopolysaccharide (LPS)-dependent activation of macrophages. Experiments
interrogating one such factor, hnRNP M, show that LPS treatment triggers dephosphorylation concomitant with
its redistribution in the nucleus. Loss of hnRNP M by shRNA-mediated knockdown in macrophages alters
alternative splicing of a number of pre-mRNAs and leads to hyper-induction of important innate immune
transcripts, including the potent inflammatory mediator IL-6 and the key viral restriction factor Mx1. This
proposal expands upon these observations, looking globally at changes to the spliceosome following
macrophage activation. It will combine high-throughput approaches, including affinity purification-mass
spectrometry, phosphoproteomics, RNA-seq, and RNA CLIP-seq with targeted genetic and biochemical
experiments to implicate specific splicing factors in driving innate immune gene expression changes. This
research program will fill key gaps in our knowledge of how splicing is regulated following macrophage
activation and further our understanding of how the spliceosome reads and interprets the splicing code not only
during innate immune activation but also during other cellular reprogramming, including differentiation, stress,
starvation, and carcinogenesis.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristin Leigh Patrick其他文献
Kristin Leigh Patrick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristin Leigh Patrick', 18)}}的其他基金
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
线粒体作为结核分枝杆菌感染期间先天免疫结果的关键调节因子
- 批准号:
10426343 - 财政年份:2021
- 资助金额:
$ 37.03万 - 项目类别:
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
线粒体作为结核分枝杆菌感染期间先天免疫结果的关键调节因子
- 批准号:
10298524 - 财政年份:2021
- 资助金额:
$ 37.03万 - 项目类别:
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
线粒体作为结核分枝杆菌感染期间先天免疫结果的关键调节因子
- 批准号:
10624436 - 财政年份:2021
- 资助金额:
$ 37.03万 - 项目类别:
Pre-mRNA splicing regulation is critical for controlling macrophage activation
前 mRNA 剪接调节对于控制巨噬细胞激活至关重要
- 批准号:
10240558 - 财政年份:2019
- 资助金额:
$ 37.03万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 37.03万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 37.03万 - 项目类别:
Research Grants